Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: G79BCDFBF14EEN
QYResearch

Abstracts

This report focuses on the global Neurological Disorder Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurological Disorder Diagnostics development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Siemens
• Philips
• GE
• Esaote
• Masimo
• Croton Healthcare
• Neusoft

Market segment by Type, the product can be split into

• Imaging Techniques
• In Vitro Diagnostics Techniques

Market segment by Application, split into

• Hospitals and Clinics
• Diagnostic Centers
• Ambulatory Care Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Neurological Disorder Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Neurological Disorder Diagnostics development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Neurological Disorder Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurological Disorder Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Neurological Disorder Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Imaging Techniques
  1.4.3 In Vitro Diagnostics Techniques
1.5 Market by Application
  1.5.1 Global Neurological Disorder Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Diagnostic Centers
  1.5.4 Ambulatory Care Centers
1.6 Coronavirus Disease 2019 (Covid-19): Neurological Disorder Diagnostics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Neurological Disorder Diagnostics Industry
    1.6.1.1 Neurological Disorder Diagnostics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Neurological Disorder Diagnostics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Neurological Disorder Diagnostics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Neurological Disorder Diagnostics Market Perspective (2015-2026)
2.2 Neurological Disorder Diagnostics Growth Trends by Regions
  2.2.1 Neurological Disorder Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Neurological Disorder Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Neurological Disorder Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Neurological Disorder Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Neurological Disorder Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Neurological Disorder Diagnostics Players by Market Size
  3.1.1 Global Top Neurological Disorder Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Neurological Disorder Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Neurological Disorder Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neurological Disorder Diagnostics Market Concentration Ratio
  3.2.1 Global Neurological Disorder Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Neurological Disorder Diagnostics Revenue in 2019
3.3 Neurological Disorder Diagnostics Key Players Head office and Area Served
3.4 Key Players Neurological Disorder Diagnostics Product Solution and Service
3.5 Date of Enter into Neurological Disorder Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Neurological Disorder Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Neurological Disorder Diagnostics Forecasted Market Size by Type (2021-2026)

5 NEUROLOGICAL DISORDER DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Neurological Disorder Diagnostics Market Size by Application (2015-2020)
5.2 Global Neurological Disorder Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Neurological Disorder Diagnostics Market Size (2015-2020)
6.2 Neurological Disorder Diagnostics Key Players in North America (2019-2020)
6.3 North America Neurological Disorder Diagnostics Market Size by Type (2015-2020)
6.4 North America Neurological Disorder Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Neurological Disorder Diagnostics Market Size (2015-2020)
7.2 Neurological Disorder Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Neurological Disorder Diagnostics Market Size by Type (2015-2020)
7.4 Europe Neurological Disorder Diagnostics Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Neurological Disorder Diagnostics Market Size (2015-2020)
8.2 Neurological Disorder Diagnostics Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2015-2020)
8.4 Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Siemens
  9.1.1 Siemens Company Details
  9.1.2 Siemens Business Overview and Its Total Revenue
  9.1.3 Siemens Neurological Disorder Diagnostics Introduction
  9.1.4 Siemens Revenue in Neurological Disorder Diagnostics Business (2015-2020))
  9.1.5 Siemens Recent Development
9.2 Philips
  9.2.1 Philips Company Details
  9.2.2 Philips Business Overview and Its Total Revenue
  9.2.3 Philips Neurological Disorder Diagnostics Introduction
  9.2.4 Philips Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.2.5 Philips Recent Development
9.3 GE
  9.3.1 GE Company Details
  9.3.2 GE Business Overview and Its Total Revenue
  9.3.3 GE Neurological Disorder Diagnostics Introduction
  9.3.4 GE Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.3.5 GE Recent Development
9.4 Esaote
  9.4.1 Esaote Company Details
  9.4.2 Esaote Business Overview and Its Total Revenue
  9.4.3 Esaote Neurological Disorder Diagnostics Introduction
  9.4.4 Esaote Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.4.5 Esaote Recent Development
9.5 Masimo
  9.5.1 Masimo Company Details
  9.5.2 Masimo Business Overview and Its Total Revenue
  9.5.3 Masimo Neurological Disorder Diagnostics Introduction
  9.5.4 Masimo Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.5.5 Masimo Recent Development
9.6 Croton Healthcare
  9.6.1 Croton Healthcare Company Details
  9.6.2 Croton Healthcare Business Overview and Its Total Revenue
  9.6.3 Croton Healthcare Neurological Disorder Diagnostics Introduction
  9.6.4 Croton Healthcare Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.6.5 Croton Healthcare Recent Development
9.7 Neusoft
  9.7.1 Neusoft Company Details
  9.7.2 Neusoft Business Overview and Its Total Revenue
  9.7.3 Neusoft Neurological Disorder Diagnostics Introduction
  9.7.4 Neusoft Revenue in Neurological Disorder Diagnostics Business (2015-2020)
  9.7.5 Neusoft Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Neurological Disorder Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Neurological Disorder Diagnostics Revenue
Table 3. Ranking of Global Top Neurological Disorder Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neurological Disorder Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging Techniques
Table 6. Key Players of In Vitro Diagnostics Techniques
Table 7. COVID-19 Impact Global Market: (Four Neurological Disorder Diagnostics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Neurological Disorder Diagnostics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Neurological Disorder Diagnostics Players to Combat Covid-19 Impact
Table 12. Global Neurological Disorder Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Neurological Disorder Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Neurological Disorder Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Neurological Disorder Diagnostics Market Share by Regions (2015-2020)
Table 16. Global Neurological Disorder Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Neurological Disorder Diagnostics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Neurological Disorder Diagnostics Market Growth Strategy
Table 22. Main Points Interviewed from Key Neurological Disorder Diagnostics Players
Table 23. Global Neurological Disorder Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Neurological Disorder Diagnostics Market Share by Players (2015-2020)
Table 25. Global Top Neurological Disorder Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Diagnostics as of 2019)
Table 26. Global Neurological Disorder Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Neurological Disorder Diagnostics Product Solution and Service
Table 29. Date of Enter into Neurological Disorder Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Neurological Disorder Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Neurological Disorder Diagnostics Market Size Share by Type (2015-2020)
Table 33. Global Neurological Disorder Diagnostics Revenue Market Share by Type (2021-2026)
Table 34. Global Neurological Disorder Diagnostics Market Size Share by Application (2015-2020)
Table 35. Global Neurological Disorder Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Neurological Disorder Diagnostics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Neurological Disorder Diagnostics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Neurological Disorder Diagnostics Market Share (2019-2020)
Table 39. North America Neurological Disorder Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Neurological Disorder Diagnostics Market Share by Type (2015-2020)
Table 41. North America Neurological Disorder Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Neurological Disorder Diagnostics Market Share by Application (2015-2020)
Table 43. Europe Key Players Neurological Disorder Diagnostics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Neurological Disorder Diagnostics Market Share (2019-2020)
Table 45. Europe Neurological Disorder Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Neurological Disorder Diagnostics Market Share by Type (2015-2020)
Table 47. Europe Neurological Disorder Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Neurological Disorder Diagnostics Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Neurological Disorder Diagnostics Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Neurological Disorder Diagnostics Market Share (2019-2020)
Table 51. Asia-Pacific Neurological Disorder Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Neurological Disorder Diagnostics Market Share by Type (2015-2020)
Table 53. Asia-Pacific Neurological Disorder Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Neurological Disorder Diagnostics Market Share by Application (2015-2020)
Table 55. Siemens Company Details
Table 56. Siemens Business Overview
Table 57. Siemens Product
Table 58. Siemens Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 59. Siemens Recent Development
Table 60. Philips Company Details
Table 61. Philips Business Overview
Table 62. Philips Product
Table 63. Philips Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 64. Philips Recent Development
Table 65. GE Company Details
Table 66. GE Business Overview
Table 67. GE Product
Table 68. GE Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 69. GE Recent Development
Table 70. Esaote Company Details
Table 71. Esaote Business Overview
Table 72. Esaote Product
Table 73. Esaote Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 74. Esaote Recent Development
Table 75. Masimo Company Details
Table 76. Masimo Business Overview
Table 77. Masimo Product
Table 78. Masimo Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 79. Masimo Recent Development
Table 80. Croton Healthcare Company Details
Table 81. Croton Healthcare Business Overview
Table 82. Croton Healthcare Product
Table 83. Croton Healthcare Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 84. Croton Healthcare Recent Development
Table 85. Neusoft Company Details
Table 86. Neusoft Business Overview
Table 87. Neusoft Product
Table 88. Neusoft Revenue in Neurological Disorder Diagnostics Business (2015-2020) (Million US$)
Table 89. Neusoft Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Neurological Disorder Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Imaging Techniques Features
Figure 3. In Vitro Diagnostics Techniques Features
Figure 4. Global Neurological Disorder Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Ambulatory Care Centers Case Studies
Figure 8. Neurological Disorder Diagnostics Report Years Considered
Figure 9. Global Neurological Disorder Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neurological Disorder Diagnostics Market Share by Regions: 2020 VS 2026
Figure 11. Global Neurological Disorder Diagnostics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neurological Disorder Diagnostics Market Share by Players in 2019
Figure 14. Global Top Neurological Disorder Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurological Disorder Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neurological Disorder Diagnostics Revenue in 2019
Figure 16. North America Neurological Disorder Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neurological Disorder Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Neurological Disorder Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Siemens Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 21. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Philips Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 23. GE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GE Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 25. Esaote Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Esaote Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 27. Masimo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Masimo Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 29. Croton Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Croton Healthcare Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 31. Neusoft Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Neusoft Revenue Growth Rate in Neurological Disorder Diagnostics Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed